Institut National De La Sante Et De La Recherche Medicale
Doing business as Inserm - Delegation Regionale Grand Ouest
Company facts
- Self-certified in SAM.gov
- Entity structure
- Country - Foreign Government
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Institut National De La Sante Et De La Recherche Medicale · Paris, Île-de-France
EJKSXFA4T326
-
Parent
Institut National De La Sante Et De La Recherche Medicale · Paris, Île-de-France
EJKSXFA4T326
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Analysis of the sharp 1 function in renal cell carcinoma - immunohistochemistry. Inserm. | National Cancer Institute (NIH) | $9,950 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Modeling hemangioblastomas using induced pluripotent stem cells carrying mutations in the VON hippel-lindau gene | Defense Health Agency | $199,908 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Washington University | R01HL148803 | $0 | |
| The Washington University | R01HL148803 | $0 | |
| Illinois Institute Of Technology | R01NS092760 | $315,179 |
Similar vendors
About the company
Institut National De La Sante Et De La Recherche Medicale, doing business as Inserm - Delegation Regionale Grand Ouest, is a French research organization registered to receive U.S. federal government awards since May 29, 2015. As a foreign government entity, Inserm primarily engages in biomedical research projects funded through federal grants. The organization has received both prime federal grant awards and sub-awards, demonstrating its involvement in collaborative international research efforts. Inserm's work focuses on advancing medical knowledge and improving healthcare outcomes through innovative scientific studies. Its expertise spans various areas of biomedical research, including tumor biology and cardiac physiology, contributing to the development of novel therapeutic approaches and deeper understanding of human health.
Inserm's recent grant activities showcase its diverse research portfolio. The organization received a $199,908 Project Grant from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to model hemangioblastomas using induced pluripotent stem cells with mutations in the von Hippel-Lindau gene. This project, scheduled for completion by April 30, 2026, aims to transform healthcare for Service Members and the American public. Additionally, Inserm participates as a sub-recipient on grants awarded to The Washington University, focusing on cardiac research. These sub-awards involve identifying native phosphorylation sites of cardiac Nav1.5 channels in the context of beta-adrenergic stimulation. The work encompasses electrophysiological analyses, mass spectrometry-based phosphoproteomic analyses, and collaboration with the Translational Cardiovascular Biobank and Repository at Washington University. These projects demonstrate Inserm's capabilities in specialized biomedical research, particularly in areas such as tumor biology and cardiac physiology, and highlight its role in international scientific collaborations aimed at advancing medical knowledge and improving patient care.
Quick answers
Is Institut National De La Sante Et De La Recherche Medicale registered in SAM.gov?
Institut National De La Sante Et De La Recherche Medicale's SAM.gov registration was deleted on March 3, 2015.
What is Institut National De La Sante Et De La Recherche Medicale's CAGE code?
Institut National De La Sante Et De La Recherche Medicale's CAGE code is FAVV6, and its Unique Entity ID (UEI) is LHTHRQEGNPW6.
What is Institut National De La Sante Et De La Recherche Medicale's most recent federal award?
Institut National De La Sante Et De La Recherche Medicale's most recent federal grant award is Modeling hemangioblastomas using induced pluripotent stem cells carrying mutations in the VON hippel-lindau gene (HT94252410059), from Defense Health Agency, on May 1, 2024.
On GovTribe
See Institut National De La Sante Et De La Recherche Medicale's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors